Industry Biotechnology Website www.tecrea.co.uk | Area served Worldwide Founded 2012 | |
Headquarters London Bioscience Innovation Centre London, United Kingdom. Services Research Reagents,Drug Development |
Tecrea Ltd is a biotech company located in the London Bioscience Innovation Centre. The company is involved in research and development to improve the cell and tissue delivery of drugs and reagents. The approach involves nanomedicine, which has the potential to address a wide variety of diseases in a safe and efficient way.
Contents
- Background
- Products
- Transfection Plasmid siRNA
- Drug Delivery Peptide Protein Small Molecule
- Sterility Maintenance
- Drug Formulation
- References
Recently Tecrea along with Cobra Biologics was awarded the Innovate UK Grant worth £112K to Develop AAV Scalable Production Bioprocess
Background
Founded in 2012, as a spinout from the Royal Veterinary College, University of London, the company has developed a line of tools that improve scientific experiments through enhanced delivery of a range of molecules into cells.
Products
Tecrea expertise in Research Reagents and Drug Formulation products
Transfection - Plasmid | siRNA
HappyFect The scientists at Tecrea Ltd have developed HappyFect™ technology to overcome major limitations with existing transfection procedures, which often suffer from difficult protocols, poor efficiency and unacceptable levels of toxicity to cultured cells. When mixed with DNA or RNA, HappyFect™ forms nanoparticles that enable efficient transfection with less toxicity There are two types of HappyFect™:- HappyFect™-PLASMID
- HappyFect™-RNAi
Drug Delivery - Peptide & Protein | Small Molecule
Nanocargo Tecrea’s NanoCargo™ products massively enhance the delivery of small molecules, peptides, and proteins, including antibodies, into a range of cell types and tissues. Nanocargo™ can even deliver cargo molecules into gram negative and gram positive bacteria. There are two types of Nanocargo™:- Nanocargo™-PRO
- Nanocargo™-SM